Point-of-care HCV RNA testing improves hepatitis C testing rates and allows rapid treatment initiation among people who inject drugs attending a medically supervised injecting facility

Bibliographic Data

ID14906359
AuthorsMichael B MacIsaac (0000-0001-9391-1468, The University of Melbourne), Bradley Whitton (St Vincent's Hospital Melbourne), Jenine Anderson, Shelley Cogger (0000-0002-4649-5753), Dylan Vella-Horne, Matthew Penn (0000-0002-5376-5299), Matthew J Penn (0000-0001-8682-5393), Anthony Weeks (0000-0001-5372-4393), Kasey Elmore, David Pemberton, Rebecca J Winter (0000-0002-2067-4278, Burnet Institute), Timothy Papaluca (0000-0003-0296-8624, The University of Melbourne), Jessica Howell (0000-0002-3558-4304, The University of Melbourne), Margaret Hellard (0000-0002-5055-3266, Burnet Institute), Mark Stoovè (0000-0003-2887-1409, Burnet Institute), David Wilson (0000-0002-6800-6447), David P Wilson (0000-0002-6855-3926, Burnet Institute), Alisa Pedrana (0000-0002-1998-5722, Burnet Institute), Joseph Doyle (0000-0001-7198-0833, Burnet Institute), Joseph S Doyle, Nicolas Clark (0000-0001-8697-6183, The Royal Melbourne Hospital), Jacinta A Holmes (0000-0002-7819-4904, The University of Melbourne), Alexander J Thompson (0000-0001-9882-0071, The University of Melbourne, corresponding author)
Year2024
Volume125
Pages104317
Publication date2024-03-01
Peer ReviewedYes
Open AccessYes
TypeARTICLE
VenueInternational Journal of Drug Policy (JOURNAL)
Journal identifiersISSN: 0955-3959 • E-ISSN: 1873-4758
PublisherElsevier BV (PUBLISHER)
DOI10.1016/j.drugpo.2024.104317
PMID38281385
OpenAlexW4391286497
LanguageEN
Citations received3
References cited43

Tools

Open DOI